Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Cancers|November 24, 2019
High Somatic Mutation and Neoantigen Burden Do Not Correlate with Decreased Progression-Free Survival in HCC Patients not Undergoing ImmunotherapyAngela Mauriello, Roberta Zeuli, Beatrice Cavalluzzo, et al.
Journal of Translational Medicine|February 27, 2021
Identification and characterization of heteroclitic peptides in TCR-binding positions with improved HLA-binding efficacyBeatrice Cavalluzzo, Concetta Ragone, Angela Mauriello, et al.
Frontiers in Immunology|July 1, 2024
Molecular mimicry of SARS-COV-2 antigens as a possible natural anti-cancer preventive immunizationConcetta Ragone, Angela Mauriello, Beatrice Cavalluzzo, et al.
Journal of Translational Medicine|December 25, 2021
Long-term memory T cells as preventive anticancer immunity elicited by TuA-derived heteroclitic peptidesAngela Mauriello, Beatrice Cavalluzzo, Carmen Manolio, et al.
Cancers|January 11, 2022
Novel Molecular Targets for Hepatocellular CarcinomaBeatrice Cavalluzzo, Angela Mauriello, Concetta Ragone, et al.
Journal of Translational Medicine|October 15, 2022
Antigenic molecular mimicry in viral-mediated protection from cancer: the HIV caseCarmen Manolio, Concetta Ragone, Beatrice Cavalluzzo, et al.
Journal for Immunotherapy of Cancer|May 29, 2021
Identification and validation of viral antigens sharing sequence and structural homology with tumor-associated antigens (TAAs)Concetta Ragone, Carmen Manolio, Beatrice Cavalluzzo, et al.
Journal of Translational Medicine|October 21, 2018
Unique true predicted neoantigens (TPNAs) correlates with anti-tumor immune control in HCC patientsAnnacarmen Petrizzo, Maria Tagliamonte, Angela Mauriello, et al.
Journal of Translational Medicine|January 25, 2020
Immunological effects of adjuvants in subsets of antigen presenting cells of cancer patients undergoing chemotherapyAngela Mauriello, Carmen Manolio, Beatrice Cavalluzzo, et al.
Oncotarget|February 10, 2018
Inhibition of tumor growth by cancer vaccine combined with metronomic chemotherapy and anti-PD-1 in a pre-clinical settingAnnacarmen Petrizzo, Angela Mauriello, Antonio Luciano, et al.
Pageof 3